{
    "organizations": [],
    "uuid": "bb4672f5cb4594478f5903ebe3d6dc90b82eb704",
    "author": "",
    "url": "https://www.reuters.com/article/brief-kalytera-initiates-program-to-deve/brief-kalytera-initiates-program-to-develop-a-novel-cannabinoid-based-compound-for-treatment-of-acute-and-chronic-pain-idUSFWN1R20DB",
    "ord_in_thread": 0,
    "title": "BRIEF-Kalytera Initiates Program To Develop A Novel Cannabinoid-Based Compound For Treatment Of Acute And Chronic Pain",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 20, 2018 / 12:14 PM / Updated 22 minutes ago BRIEF-Kalytera Initiates Program To Develop A Novel Cannabinoid-Based Compound For Treatment Of Acute And Chronic Pain Reuters Staff 1 Min Read March 20 (Reuters) - Kalytera Therapeutics Inc: * KALYTERA INITIATES PROGRAM TO DEVELOP A NOVEL CANNABINOID-BASED COMPOUND FOR TREATMENT OF ACUTE AND CHRONIC PAIN * KALYTERA THERAPEUTICS INC - ‍KALYTERA OBTAINED AN EXCLUSIVE, WORLDWIDE LICENSE FOR COMPOUND FROM BEETLEBUNG PHARMA, LTD​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-20T14:11:00.000+02:00",
    "crawled": "2018-03-20T14:46:13.032+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "initiate",
        "program",
        "develop",
        "novel",
        "compound",
        "treatment",
        "acute",
        "chronic",
        "pain",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "kalytera",
        "therapeutic",
        "inc",
        "kalytera",
        "initiate",
        "program",
        "develop",
        "novel",
        "compound",
        "treatment",
        "acute",
        "chronic",
        "pain",
        "kalytera",
        "therapeutic",
        "inc",
        "obtained",
        "exclusive",
        "worldwide",
        "license",
        "compound",
        "beetlebung",
        "pharma",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}